Stay informed with the latest litigation news. Explore now

IP Verse

Dosage Form Containing Oxycodone And Naloxone - EP2962686B1

EP2962686

EURO CELTIQUE
Application Number
EP15180143A
Filing Date
Feb 28, 2006
Status
Revoked
Oct 22, 2021
Grant Date
Apr 10, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3578173B1
EP2568967B2
EP2706982B2

Bibliography

The patent EP2962686B1 was granted to Euro Celtique on Apr 10, 2019 following the initial filing on Feb 28, 2006 under the application number EP15180143A . The current legal status of the patent is Revoked.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ARISTO PHARMAJan 9, 2020ADMISSIBLE
ETHYPHARMJan 9, 2020ADMISSIBLE
TEVA PHARMACEUTICALSJan 9, 2020ADMISSIBLE
KRKASep 24, 2019ADMISSIBLE
STADA ARZNEIMITTELAug 8, 2019ADMISSIBLE
DEVELCO PHARMA SCHWEIZApr 11, 2019ADMISSIBLE
HEXAL SANDOZApr 11, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents